Search

everythinglearnresearchcommunity

for

Search:↓

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Azathioprine can cause unexpected hair loss and severe bone marrow issues, so careful monitoring is needed.

JAK1 inhibitor may effectively treat alopecia areata when TNF-α inhibitors and corticosteroids fail.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

α-parvin is necessary for skin and hair growth and for the correct orientation of skin cells.

A woman's rare hair loss condition improved on its own, suggesting this type might recover like common cases.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Non-obese women with hair loss have higher heart disease risk.

Painful hair loss in an elderly woman was caused by giant cell arteritis, not just aging.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

An 84-year-old man developed severe anemia after his first COVID-19 vaccine shot, improved with treatment, and was advised against a second dose.

Alopecia areata involves unique activation of certain immune cells.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

A woman with lupus and antiphospholipid syndrome had bone damage, showing the need for careful treatment.

Certain gene variations in PITX2 are linked to a higher risk of male pattern baldness in Indians.

Upadacitinib may effectively treat resistant lichen planopilaris.

A new mutation in the ST14 gene was found in a patient with ARIH syndrome, showing milder symptoms and no tooth issues.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

Alopecia areata patients are more likely to have thyroid disorders than healthy individuals.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

Baricitinib helps grow eyebrows and eyelashes in severe alopecia areata patients.